Keywords: CCI; Charlson Comorbidity index; DCR; Danish Cancer Registry; GP; general practitioner; IQI; Interquartile interval; NPR; National Patient Registry; Other/no-diagnosis; other or no diagnosis; Urgent referral; Neoplasm; Mortality; Primary health care; Denm
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ACS; American college of surgeons; BMP; beats per minute; CI; confidence interval; CT; computerized tomography; DCR; damage control resuscitation; EMS; emergency medical services; ICU; intensive care unit; INR; international normalized ratio; IQR; interqu
Keywords: BACE; bronchial arterial chemoembolization; CBM; China biological medicine database; CNKI; China national knowledge infrastructure database; CENTRAL; Cochrane Central Register of Controlled Trials; Chi-CTR; Chinese clinical trial registry; DCR; disease co
Keywords: Discards reduction; VMS; GAM; Landing obligation; Hot spot analysis; Mediterranean Sea; CFP; Common Fisheries Policy; DCR; Data Collection Regulation; DPUE; Discards Per Unit Effort; DF; Discarded Fish; DMLS; Discarded species with MLS; DnonMLS; Discarded
Keywords: 5FU; 5-fluorouracil; 95%CI; 95% confidence interval; AA; amino acid; AFP; alpha fetoprotein; AML; actue myeloid leukemia; Ang2; angiopoietin 2; ATP; adenosine triphosphate; BCLC; Barcelona-Clinic Liver Cancer classification; BSC; best supportive care; CAP
Keywords: comorbidity; cutaneous T-cell lymphoma; deep venous thrombosis; mycosis fungoides; parapsoriasis; pulmonary embolism; venous thromboembolism; CI; confidence interval; DCR; Danish Cancer Registry; DNRP; Danish National Registry of Patients; DVT; deep venou
Keywords: Eribulin; Metastatic breast cancer; First-line; Microtubule; Dose-intensity; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; CR; complete response; DCR; disease control rate; DOR; duration of response; ECOG PS; Eas
Keywords: DCR; Danish Cancer Registry; GP; general practitioner; NPR; National Patient Registry; Early cancer diagnosis; Neoplasm; Urgent referral; Denmark; General practice;
Keywords: Triage; Trauma; Combat casualty; Massive transfusion; Damage control; Echography; ABC-score; Assessment of blood consumption-score; CRAMS-scale; Circulation Respiratory Abdomen Motor and Speech-scale; DCR; Damage control resuscitation; DCS; Damage control
Keywords: DCR; 2D, 3D, inversion; Apparent electromagnetic conductivity; Disposal area; Leachate; Heavy metal; Pollution;
Keywords: A5 (A10); amplitude of clot firmness 5 (10) minutes after CT; BW; body weight; CFT; clot formation time; Cryo; cryoprecipitate; CT; clotting time; DCR; damage control resuscitation; ED; Emergency Department; FC; fibrinogen concentrate; FibC; clauss fibrin
Design, selection, and development of cyclic peptide ligands for human erythropoietin
Keywords: AC; affinity chromatography; BSA; bovine serum albumin; CHAPS; 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate; CHO; Chinese hamster ovary; DCM; dichloromethane; DCR; divide couple re-combine; DIPEA; diisopropylethylamine; DMF; N,N-dimethylform
Keywords: DCR; disease control rate; D-ILD; drug-induced interstitial lung disease; EGFR-TKI; epidermal growth factor receptor-tyrosine kinase inhibitor; NSCLC; non-small-cell lung cancer; ORR; objective response rate; OS; overall survival; PD; progressive disease,
Keywords: FiT; Feed-in-Tariff; RPO; Renewable Purchase Obligation; PPA; Purchase Agreements; REC; Renewable Energy Certificates; AD; Accelerated Depreciation; NSM; National Solar Mission; PSU; Public Sector Undertaking; RET; Renewable Energy Technology; CERC; Centr
Keywords: Anisotropy; Apparent resistivity tensor; DCR; Modeling
Keywords: Fragility function; Concrete dam; Earthquake; Uncertainty quantification; Damage; 2D; two-dimensional; 3D; three-dimensional; AD; Anderson-Darling test; AIC; Akaike information criterion; ASCE; American Society of Civil Engineers; ASDSO; Association of St
Keywords: Colorectal Neoplasm; Colon Cancer; Interval Cancer; Surveillance; CI; confidence interval; CRC; colorectal cancer; DCR; Danish Cancer Registry; dMMR; mismatch repair deficiency; IHC; immunohistochemistry; OR; odds ratio;
Keywords: Endoscopic dacryocystorhinostomy; Endoscopic DCR; Lacrimal apparatus; Maxillary line; Nasolacrimal duct; Nasolacrimal canal; DCR; dacryocystorhinostomy; NLD; nasolacrimal duct; M-point; maxillary line midpoint; NL; nasolacrimal;
Keywords: AAVA; anti-annexin V antibodies; AECA; anti-endothelial cell antibodies; Ang; angiopoietin; ANGPTL; angiopoietin-like protein; AT1R; antibodies against angiotensin II type 1 receptor; CCR; chemokine receptor; dcSSc; diffuse cutaneous systemic sclerosis; D
Keywords: CCI; Charlson Comorbidity Index; CRS; Civil Registration System; DCR; Danish Cancer Registry; DNRP; Danish National Registry of Patients; MMR; mortality rate ratio; SRE; skeletal-related event; Bone metastasis; Lung cancer; Cohort study; Mortality; Skelet
Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines
Keywords: ADRs; adverse drug reactions; AMI; astragalus membranaceus injection; CNKI; China national knowledge infrastructure database; CBM; China biological medicine database; CR; complete response; CI; confidence interval; CTCAE 3.0; Common Terminology Criteria f
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer
Keywords: ALK; anaplastic lymphoma kinase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BSA; body surface area; Ccr; creatinine clearance; CI; confidence interval; CR; complete response; CTCAE; common terminology criteria for adverse events; DCR;
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
Keywords: ILD; interstitial lung disease; IPF; idiopathic pulmonary fibrosis; AE; acute exacerbation; AE-ILD; acute exacerbation of interstitial lung disease; NSCLC; non-small cell lung cancer; S-1; tegafur-gimeracil-oteracil potassium; CBDCA; carboplatin; RECIST;
Efficacy and safety of nivolumab in previously treated patients with non-small cell lung cancer: A multicenter retrospective cohort study
Keywords: AE; adverse event; ALK; anaplastic lymphoma kinase; CR; complete response; DCR; disease control rate; ECOG PS; Eastern Cooperative Oncology Group Performance Status; EGFR; epidermal growth factor receptor; HR; hazard ratio; irAE; immune related adverse ev
Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting
Keywords: CI; confidence interval; DCR; disease control rate; DOC; docetaxel; EMA; European Medicines Agency; FDA; US Food and Drug Administration; HR; hazard ratio; ITT; intent to treat; NSCLC; non-small cell lung cancer; OR; odds ratio; ORR; objective response ra
The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia
Keywords: TRAIL; TNF-related apoptosis-inducing ligand; XIAP; X-linked inhibitor of apoptosis protein; cFLIP; cellular FLICE-inhibitory protein; bcl-2; B-cell lymphoma 2; IAP; inhibitor of apoptosis proteins; Mcl-1; myeloid cell leukemia-1; Apo-2L; Apo2 ligand; DR;
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives
Keywords: NNSCLC; non-small cell lung cancer; OS; overall survival; EGFR; epidermal growth factor receptor; TKI; tyrosine kinase inhibitor; ALK; Anaplastic lymphoma kinase; MET; mesenchymal epithelial transition factor; PFS; progression free survival; HER2; human e
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial
Keywords: CM; complementary medicine; CT; computerized tomography; DCR; disease control rate; ECOG PS; Eastern Cooperative Oncology Group performance status; EMA; European Medicines Agency; EORTC QLQ-C30; European Organization for Research and Treatment of Cancer Q
CT-response patterns and the role of CT-textural features in inoperable abdominal/retroperitoneal soft tissue sarcomas treated with trabectedin
Keywords: CI; ConfidenceInterval; CT; ComputedTomography; CTTA; CT-TexturalAnalysis; DCR; Disease Control Rate; DNA; DeoxyribonucleicAcid; FDG-PET; Fludeoxyglucose-Positron Emission Tomography; Fig.; Figure; GIST; Gastrointestinal Stromal Tumor; NGLD; MNeighboring
Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer
Keywords: BID; twice daily; CARBO-ETOP; carboplatin-etoposide therapy; CDK; cyclin-dependent kinase; CI; confidence interval; CIS-ETOP; cisplatin-etoposide therapy; DCR; disease control rate; DLT; dose-limiting toxicity; DoR; duration of response; ED-SCLC; extensiv
Aidi injection plus platinum-based chemotherapy for stage IIIB/IV non-small cell lung cancer: A meta-analysis of 42 RCTs following the PRISMA guidelines
Keywords: NSCLC; non-small cell lung cancer; PBC; platinum-based chemotherapy; CR; complete response; PR; partial response; NC; no change; SD; stable disease; PD; progressive disease; ORR; objective response rate; DCR; Disease Control Rate; KPS; karnofsky performan
Geographic variation in RNAi sensitivity in the migratory locust
Keywords: RNAi; RNA interference; Crz; corazonin; dsRNA; double-stranded RNA; MD; Minami-Daito Island; IB; Ibaraki; TS; Tsushima Island; HK; Hokkaido Island; EcR; ecdysone receptor; Ago; Argonaute; Dcr; Dicer; SID-1; systemic RNAi defective-1; BLAST; basic local al
Elevated plasma vitamin B12 levels and risk of venous thromboembolism among cancer patients: A population-based cohort study
Keywords: Cbl; Cobalamin, vitamin B12; CCI; Charlson Comorbidity Index; CI; Confidence interval; CPR; Civil Personal Registration; CRS; Civil Registration System; DCR; Danish Cancer Registry; DNPR; Danish National Patient Registry; DVT; Deep venous thrombosis of th
Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study
Keywords: AE; adverse event; CI; confidence interval; DBS; dried blood spot; DCR; disease control rate; ECOG PS; Eastern Cooperative Oncology Group performance status; EGFR; epidermal growth factor receptor; HER; human epidermal growth factor receptor; HR; hazard r
SituResp®: A time- and cost-effective method to assess basal soil respiration in the field
Keywords: BSR; Basal Soil Respiration; CV; Coefficient of Variation; DCR; Digital Score Reader; max; Maximum; min; Minimum; OD; Optical Density; Basal soil respiration; SituResp®; Solvita®; Indicator; Soil microbial activity; Soil quality;
Magnetic implants in the tongue for assistive technologies: Tests of migration; oromotor function; and tissue response in miniature pigs
Keywords: HE; hematoxylin and eosin; PS; picrosirius red; SCI; spinal cord injury; TDS; tongue drive system; Ti-Mag; titanium-encased magnet; DCD; drink cycle duration; DCR; drink cycle rate; Tongue; Tongue drive system; Magnet; Spinal cord injury;
PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review
Keywords: ALK; anaplastic lymphoma kinase; CI; confidence interval; ECOG; The Eastern Cooperative Oncology Group; DCB; durable clinical benefit; DCR; disease control rate; EGFR; epidermal growth factor receptor; EGFRm+; EGFR mutation positive; FDA; Food and Drug Ad
Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology: A Population-Based Study
Keywords: CD; NET; intestinal cancer; UC; CD; Crohn's disease; CRC; colorectal cancer; DCR; Danish Cancer Registry; DPR; Danish Pathology Register; H&E; hematoxylin and eosin; IBD; inflammatory bowel disease; ICD; International Classification of Diseases; IHC; im
Bicanalicular Silicone Stents in Endonasal Dacryocystorhinostomy
Keywords: CI; confidence interval; DCR; dacryocystorhinostomy; EN-DCR; endonasal dacryocystorhinostomy;
Elevated plasma vitamin B12 levels and cancer prognosis: A population-based cohort study
Keywords: ATC; anatomical therapeutic chemical; AUPD; Aarhus University Prescription Database; Cbl; cobalamin, vitamin B12; CCI; Charlson comorbidity index; CI; confidence interval; CPR; Civil Personal Registration; DCR; Danish Cancer Registry; DNRP; Danish Nationa
A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy
Keywords: AE; adverse event; CI; confidence interval; CR; complete response; CT; computed tomography; DCR; disease control rate; ECOG; Eastern Cooperative Oncology Group; EGFR; epidermal growth factor receptor; FAS; full analysis set; HR; hazard ratio; ILD; interst
Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation study
Keywords: BBB; blood-brain barrier; BCRP; breast cancer-resistant protein; CIs; confidence intervals; CSF; cerebrospinal fluid; CT; computed tomography; DCR; disease control rates; DLT; dose-limiting toxicity; ECOG; Eastern Cooperative Oncology Group; EC-PFS; ext
An update on the stereoselective synthesis of γ-amino acids
Keywords: ABO; 2,7,8-trioxabicyclo[3.2.1]octane; Ac; acetyl; ACPECA; 4-aminocyclopent-2-ene-1-carboxylic acid; AHPPA; 4-amino-3-hydroxy-5-phenylpentanoic acid; AMCP; 2-(aminomethyl)-cyclopentanecarboxylic acid; APCH; 2-(1-aminopropyl)cyclohexanecarboxylic acid; APT
Optimal design of trials to demonstrate the utility of genomically-guided therapy: Putting Precision Cancer Medicine to the test
Keywords: Clinical trial design; Precision Cancer Medicine; Targeted therapy; CSC; Cancer stem cell; COSMIC; Catalogue of Somatic Mutations in Cancer; CTC; Circulating tumor cell; ctDNA; Circulating tumor DNA; CRC; Colorectal cancer; DCR; Disease control rate; EMA;
Phase I study of the HER3-targeted antibody patritumab (U3-1287) combined with erlotinib in Japanese patients with non-small cell lung cancer
Keywords: HER; human epidermal growth factor receptor; NSCLC; non-small cell lung cancer; DLT; dose-limiting toxicity; MTD; maximum tolerated dose; EGFR-TKI; epidermal growth factor receptor-tyrosine kinase inhibitor; RECIST; response evaluation criteria in solid t
Regulation of cell fate by lymphotoxin (LT) receptor signalling: Functional differences and similarities of the LT system to other TNF superfamily (TNFSF) members
Keywords: Lymphotoxin; CD40; Apoptosis; Receptor cross-linking; Cell signalling; AP-1; activator protein-1; APRIL; a proliferation-inducing ligand; BAFF; B-cell activating factor belonging to the TNF family; CLL; chronic lymphocytic leukaemia; DD; death domain; DR;
Lens culinaris agglutinin-reactive α-fetoprotein decline after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma predicts survival
Keywords: HCC; hepatocellular carcinoma; AFP; α-fetoprotein; AFP-L3; Lens culinaris agglutinin-reactive α-fetoprotein; LCA; Lens culinaris agglutinin; Con A; concanavalin A; TACE; transcatheter arterial chemoembolization; Lectin dual-label TRFIAs; lectin dual-lab
Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study)
Keywords: BRCA1; breast cancer susceptibility gene 1; CI; confidence interval; DCR; disease control rate; DNA; deoxyribonucleic acid; ERCC1; enzyme repair cross-complementation group 1; FasL; Fas ligand; HES; hematoxylin-eosin-saffron; IHC; immunohistochemistry
Subsequent cancers, mortality, and causes of death in patients with mycosis fungoides and parapsoriasis: AÂ Danish nationwide, population-based cohort study
Keywords: causes of death; cutaneous T-cell lymphoma; mortality; mycosis fungoides; parapsoriasis; subsequent cancers; CI; confidence interval; CTCL; cutaneous T-cell lymphoma; DCR; Danish Cancer Registry; ICD; International Classification of Diseases; MF; mycosis
Risk of Cancer in Patients With Inflammatory Bowel Diseases: AÂ Nationwide Population-based Cohort Study With 30 Years of Follow-up Evaluation
Keywords: Epidemiology; Crohn's Disease; Ulcerative Colitis; Colorectal Cancer; GI Tumor; CD; Crohn's disease; CI; confidence interval; DCR; Danish Cancer Registry; DNPR; Danish National Patient Register; IBD; inflammatory bowel disease; ICD; International Clas